Mylan became the latest pharmaceutical company to face outrage about higher drug costs after the company’s substantial price increases for the EpiPen emergency allergy treatment.
WSJ.com: Health, Wall Street Journal: Business: Health
Wed, 08/24/2016 - 7:58pm